FDA declines to review Moderna’s flu mRNA vaccine application, company says
The U.S. Food and Drug Administration has declined to accept a request from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology that has been the target of Trump administration health officials. The agency told Moderna that its application did not contain an “adequate and … Read more